B regulatory cells in cancer

被引：99

作者：

Balkwill, Frances ^{[1
]}

Montfort, Anne ^{[1
]}

Capasso, Melanie ^{[1
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England

来源：

TRENDS IN IMMUNOLOGY | 2013年 / 34卷 / 04期

关键词：

B cells; B regulatory cells; interleukin-10; cancer; anti-CD20; immunosuppression; T-CELLS; CD20; IMMUNOTHERAPY; LYMPHOMA DEPLETION; B10; CELLS; MICE; IL-10; LYMPHOCYTES; SUBSET; TUMORS; AUTOIMMUNITY;

D O I：

10.1016/j.it.2012.10.007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

B regulatory cells are a newly described subpopulation of B cells that appear to play important roles in autoimmunity and more recently, in cancer. In this review we summarize our current knowledge of B regulatory cells, as well as the body of evidence pointing towards a role for B cells in general, and B regulatory cells in particular, in promoting tumor growth.

引用

页码：169 / 173

页数：5

共 39 条

[1] B-cell-derived lymphotoxin promotes castration-resistant prostate cancer [J].

Ammirante, Massimo ;

Luo, Jun-Li ;

Grivennikov, Sergei ;

Nedospasov, Sergei ;

Karin, Michael .

NATURE, 2010, 464 (7286) :302-U187

[2] FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis [J].

Andreu, Pauline ;

Johansson, Magnus ;

Affara, Nesrine I. ;

Pucci, Ferdinando ;

Tan, Tingting ;

Junankar, Simon ;

Korets, Lidiya ;

Lam, Julia ;

Tawfik, David ;

DeNardo, David G. ;

Naldini, Luigi ;

de Visser, Karin E. ;

De Palma, Michele ;

Coussens, Lisa M. .

CANCER CELL, 2010, 17 (02) :121-134

[3] B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion [J].

Barbera-Guillem, E ;

Nelson, MB ;

Barr, B ;

Nyhus, JK ;

May, KF ;

Feng, L ;

Sampsel, JW .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) :541-549

[4] CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients [J].

Blair, Paul A. ;

Norena, Lina Yassin ;

Flores-Borja, Fabian ;

Rawlings, David J. ;

Isenberg, David A. ;

Ehrenstein, Michael R. ;

Mauri, Claudia .

IMMUNITY, 2010, 32 (01) :129-140

[5]

BRODT P, 1982, CANCER IMMUNOL IMMUN, V13, P125

[6] Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis [J].

Carter, Natalie A. ;

Rosser, Elizabeth C. ;

Mauri, Claudia .

ARTHRITIS RESEARCH & THERAPY, 2012, 14 (01)

[7] IMMUNOGLOBULIN GENE REARRANGEMENT IN B-CELL DEFICIENT MICE GENERATED BY TARGETED DELETION OF THE J(H) LOCUS [J].

CHEN, JZ ;

TROUNSTINE, M ;

ALT, FW ;

YOUNG, F ;

KURAHARA, C ;

LORING, JF ;

HUSZAR, D .

INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) :647-656

[8] Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor? [J].

de Lafaille, Maria A. Curotto ;

Lafaille, Juan J. .

IMMUNITY, 2009, 30 (05) :626-635

[9] Paradoxical roles of the immune system during cancer development [J].

de Visser, KE ;

Eichten, A ;

Coussens, LM .

NATURE REVIEWS CANCER, 2006, 6 (01) :24-37

[10] De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent [J].

de Visser, KE ;

Korets, LV ;

Coussens, LM .

CANCER CELL, 2005, 7 (05) :411-423

← 1 2 3 4 →